Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET

Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL

NCT05113576 ·Status: COMPLETED

CD70-targeted immunoPET Imaging of Malignant Cancers

NCT06852638 ·Status: RECRUITING ·Phase: PHASE2

The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma

NCT06863441 ·Status: NOT_YET_RECRUITING

Positron Emission Tomography (PET)-Scan in the Evaluation of High Tumor Burden Follicular Lymphoma

NCT00915096 ·Status: COMPLETED

PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions

NCT06602674 ·Status: COMPLETED

FDG-PET/CT Imaging as Early Predictor of DP

NCT02476734 ·Status: COMPLETED

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

NCT06795113 ·Status: RECRUITING

Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma

NCT04367948 ·Status: UNKNOWN ·Phase: NA

18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma

NCT03051581 ·Status: UNKNOWN ·Phase: NA

Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors

NCT04989010 ·Status: UNKNOWN ·Phase: NA

18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma

NCT04317313 ·Status: COMPLETED

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

NCT02325349 ·Status: TERMINATED ·Phase: PHASE2

Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma

NCT06777290 ·Status: COMPLETED

Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET

NCT04992156 ·Status: COMPLETED

18F-mFBG PET Imaging in the Evaluation of Neuroblastoma

NCT06852807 ·Status: RECRUITING

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

NCT01004718 ·Status: COMPLETED ·Phase: NA

Detection and Characterization of Residual Masses in Lymphomas

NCT02300402 ·Status: COMPLETED

The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma

NCT00498667 ·Status: WITHDRAWN

PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma

NCT05565898 ·Status: NOT_YET_RECRUITING

18F-FAPI PET/CT in Patients With Various Types of Cancer

NCT05810324 ·Status: UNKNOWN ·Phase: NA

18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma

NCT03121456 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy

NCT04913896 ·Status: UNKNOWN

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma

NCT00530179 ·Status: COMPLETED ·Phase: NA

Treatment of Primary CNS Lymphoma ( FTD )

NCT05274139 ·Status: COMPLETED ·Phase: PHASE2

Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT

NCT00256490 ·Status: COMPLETED ·Phase: NA